Brain tumors and neuro-oncology are integral to addressing the complexities of primary and secondary brain cancers. This specialized field encompasses a range of treatment options, from surgery and radiation therapy to cutting-edge drug therapies and clinical trials exploring new drug combinations. Researchers are focused on overcoming the challenges posed by the blood-brain barrier to deliver effective treatments. With the advent of immunotherapy, CAR-T cell therapies, and personalized genetic profiling, the landscape of neuro-oncology is rapidly changing. The development of non-invasive diagnostic tools and predictive models is also helping clinicians better assess tumor behavior and patient prognosis. This research is instrumental in improving long-term outcomes and offering hope to patients affected by malignant brain tumors.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States